MyAverix Finance
TO · Healthcare
Crescita Therapeutics Inc (CTX)
Drug Manufacturers - Specialty & Generic
Crescita Therapeutics Inc (CTX) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CTX
Crescita Therapeutics Inc (CTX) — FAQ
What is CTX's P/E ratio?
The price-to-earnings (P/E) ratio for Crescita Therapeutics Inc (CTX) is 18.00 (data as of 2026-05-24).
Does Crescita Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Crescita Therapeutics Inc (CTX). Check the MyAverix Finance app for the latest dividend data.
What sector is Crescita Therapeutics Inc in?
Crescita Therapeutics Inc (CTX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CTX listed on?
CTX is listed on TO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.